The Europe joint pain injection market is expected to grow from US$ 595.20 million in 2021 to US$ 1,035.54 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.
Companies operating in the joint pain injection market are undertaking an increasing number of research and development activities to introduce more innovative products. The injection has the ability to restore the viscosity and elasticity of synovial fluid, thereby decreasing pain and inflammation as well as increasing mobility of the affected organ and reducing friction between bones. Additionally, in November 2017, Flexion Therapeutics Inc. launched Zilretta, an intra-articular injection for OA knee pain. It is a non-opioid medicine that has Flexion’s proprietary microsphere technology and offers pain relief for 12 weeks among the patients with osteoarthritis of knee. Furthermore, in July 2019, Teva Pharmaceutical Industries Ltd. launched 1% Sodium Hyaluronate used to treat of patients with OA-related knee pain; the product is especially prescribed to patients who have failed to respond to conservative non-pharmacologic therapy and simple analgesics. Such increasing number of product developments and launches are emerging as an important trend in the joint pain injection market
Several European countries witnessed an unprecedented rise in the number of COVID-19 cases, which led to the discontinuation of several business operations and manufacturing activities of various healthcare products, including joint pain injections, which negatively impacted the joint pain injection market. Also, the pandemic has halted the adoption of new medical device policy and delayed clinical trials and disrupted processes. Two consecutive waves of coronavirus had devastating impact on economic activities in the Europe. Implementation of social distancing and lockdown policies led to closing of orthopedic hospitals and patient visits for elective orthopedic surgeries. This factor negatively impacted the adoption of joint pain injection. In addition, disrupted supply chains, extended lockdowns, and cancelling of orthopedic medical procedures have also negativity affected the growth of the joint pain injection market. The hospitals in the region are cancelling other surgical procedures to keep healthcare facilities free for COVID-19 patients. Moreover, increasing COVID-19 infection in healthcare workers is leading to shortage of staff. These factors are negatively impacting the growth of the joint pain injection market.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe Joint Pain Injection Market Segmentation
Europe Joint Pain Injection Market – By Drugs
- Hyaluronic Acid
- Corticosteroid
- Others
Europe Joint Pain Injection Market – By Joint Type
- Knee
- Foot and Ankle
- Shoulder and Elbow
- Hip
- Others
Europe Joint Pain Injection Market – By Distribution Channel
- Retail Pharmacies
- Hospitals Pharmacies
- Others
Europe Joint Pain Injection Market – By Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Drugs, Joint Type, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Joint Pain Injection Market – By Drugs
1.3.2 Europe Joint Pain Injection Market – By Joint Type
1.3.3 Europe Joint Pain Injection Market – By Distribution Channel
1.3.4 Europe Joint Pain Injection Market – By Country
2. Europe Joint Pain Injection Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Joint Pain Injection – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. Joint Pain Injection Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Incidences of Musculoskeletal Disorders
5.1.2 Hike in the Number of Sports Injuries
5.2 Market Restraints
5.2.1 Huge Costs of Joint Repair Therapies
5.3 Market Opportunities
5.3.1 Development of Pharmaceutical Sector in Emerging Markets
5.4 Future Trends
5.4.1 Rapid Innovation in Products
5.5 Impact Analysis
6. Joint Pain Injection Market – Europe Analysis
6.1 Europe Joint Pain Injection Market Revenue Forecast and Analysis
6.2 Europe Joint Pain Injection Market, By Country - Forecast and Analysis
7. Europe Joint Pain Injection Market Analysis – By Drugs
7.1 Overview
7.2 Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
7.3 Hyaluronic Acid
7.3.1 Overview
7.3.2 Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Corticosteroid
7.4.1 Overview
7.4.2 Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Joint Pain Injection Market Analysis – By Joint Type
8.1 Overview
8.2 Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
8.3 Knee
8.3.1 Overview
8.3.2 Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hip
8.4.1 Overview
8.4.2 Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Foot and Ankle
8.5.1 Overview
8.5.2 Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Shoulder and Elbow
8.6.1 Overview
8.6.2 Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Joint Pain Injection Market Analysis – By Distribution Channel
9.1 Overview
9.2 Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028, (%)
9.3 Hospitals Pharmacies
9.3.1 Overview
9.3.2 Hospitals Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Joint Pain Injection Market – Country Analysis
10.1 Europe: Joint Pain Injection Market Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 Europe: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
10.1.3 Germany: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 Germany: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 Germany: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.3.3 Germany: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.3.4 Germany: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.4 UK: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 UK: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 UK: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.4.3 UK: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.4.4 UK: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.5 France: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.1 France: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.2 France: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.5.3 France: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.5.4 France: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6 Italy: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1 Italy: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Italy: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.6.3 Italy: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.6.4 Italy: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.7 Spain: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.1 Spain: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.2 Spain: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.7.3 Spain: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.7.4 Spain: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.8 Rest of Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Rest of Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Rest of Europe: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.8.3 Rest of Europe: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.8.4 Rest of Europe: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Joint Pain Injection Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Europe Joint Pain Injection Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Chugai Pharmaceutical Co., Ltd.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bioventus Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Fidia Pharma USA Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Seikagaku Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ferring B.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Sanofi
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Anika Therapeutics, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Teva Pharmaceutical Industries Ltd.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Joint Pain Injection Market –Revenue and Forecast To 2028 (US$ Million)
Table 2. Germany Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 5. UK Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 6. UK Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 7. UK Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 8. France Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 9. France Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 10. France Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. Italy Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 12. Italy Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 13. Italy Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 14. Spain Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Spain Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Europe Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Europe Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Europe Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, Joint Pain Injection Market
LIST OF FIGURES
Figure 1. Joint Pain Injection Market Segmentation
Figure 2. Europe Joint Pain Injection Market Segmentation, By Country
Figure 3. Joint Pain Injection Market Overview
Figure 4. Knee Joint Type Segment Held Largest Share of Joint Pain Injection Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe Joint Pain Injection Market, Industry Landscape
Figure 7. Europe PEST Analysis
Figure 8. Joint Pain Injection Market Impact Analysis of Driver and Restraints
Figure 9. Europe Joint Pain Injection Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
Figure 11. Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
Figure 15. Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028 (%)
Figure 21. Hospitals Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)
Figure 25. Europe: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
Figure 26. Germany: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. UK: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. France: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Italy: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Spain: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Rest of Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
- Chugai Pharmaceutical Co., Ltd.
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Seikagaku Corporation
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- Teva Pharmaceutical Industries Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Joint Pain Injection Market
Sep 2021
Therapeutic Vaccines Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Cancer Vaccines, Infectious Disease Vaccines, and Others), Technology (Allogenic Vaccines and Autologous Vaccines), End User (Hospitals, Clinics, and Others), and Geography
Sep 2021
Medical Cables Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Disposable Medical Cables, Reusable Medical Cables, and Custom Medical Cables), Applications [Diagnostics (Ultrasound Cables, Endoscopy Cables, Patient Interface Cables, and Others), Motorized Equipment, Patient Monitoring (ECG Cables, SpO2 Cables, NiBP Cables, EEG Cables, and Others), Surgical and Life Support (Fiber Optics, Modular Local Area Network, and Others), and Others], End User (Hospital and Clinics, Diagnostic Laboratories and Imaging Centers, Ambulatory Surgical Centers, and Others), and Geography
Sep 2021
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Sep 2021
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Sep 2021
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Sep 2021
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Sep 2021
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Sep 2021
Infusion Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Infusion Pumps Pumps [Volumetric Pumps, Syringe Pumps, Insulin Pumps, Patient Control Analgesia (PCA) Pumps, Enteral Pumps, Implantable Pumps, and Elastomeric Pumps] and Infusion Sets [Vented Infusion Sets and Non-Vented Infusion Sets], Application (Diabetes, Oncology, Pain Management, Hematology, Pediatrics, Gastroenterology, and Others), End User (Hospitals and Specialty Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others), and Geography
Get Free Sample For